相关实验视频
Updated: Jul 5, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
阿布罗西提尼布作为多种皮肤疾病的新疗法:3个病例报告和范围审查
Pingjiao Chen1, Jingyao Liang2,3, Changxing Li1
1Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.
阿布罗西提尼布是一种JAK 1抑制剂,在治疗超越亚托皮炎的各种炎症性皮肤疾病方面表现出有效性和良好的耐受性. 这扩大了其在皮肤病学中的潜在治疗应用.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 简氏激酶 (JAK) 抑制剂对于治疗炎症性皮肤疾病非常有价值.
- 阿布罗西替尼是口服的JAK 1抑制剂,在治疗中度至重度的亚托皮性皮炎 (AD) 中表现出有效性.
更多相关视频
08:30A Novel High-Throughput Ex Vivo Ovine Skin Wound Model for Testing Emerging Antibiotics
Published on: September 16, 2022
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
相关概念视频
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Abnormal Proliferation